CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 



Casi Pharmaceuticals, Inc.  (CASI)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 

Casi Pharmaceuticals Growth Comparisons

Select each growth Category to receive further Information

Select the Comparisons : Select the Ratio:                        

CASI Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) - -2.64 % 5.51 % 6.92 %
Q / Q Revenue Growth (Q4 MRQ) - -4.33 % 1.48 % -4.33 %
Y / Y Revenue Growth (for 12 months ending Q4 TTM) - 0.24 % 3.39 % %
Seq. Revenue Growth (for 12 months ending Q4 TTM) - -1.4 % 0.93 % 2.75 %
Revenue 5 Year Average Growth - 7.08 % 9.82 % 14.1 %
Expected Revenue Growth (Y/Y) - - 1.89 % 2.7 %


CASI's Growth Comparisons in IV. Quarter 2016


You need to upgrade your Flash Player


Casi Pharmaceuticals reported top-line of$ -0 millions in the forth quarter 2016, compare to $ -0 millions in the same quarter a year ago. Biotechnology & Drugs industry fell by -2.64%, while Healthcare sector increased by 5.51%, and overall market improved by 6.92%.

Sequentially company's Revenue were unchanged from the forth quarter results. . Looking into annual growth, sales grew by % on average in last five years, while S & P 500's including only Businesses with the forth quarter 2016 earnings reports, average yearly sales growth is 14.1%.


Growth Rates of CASI's Income in the forth quarter 2016


CASI Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) -46.42 % -13.36 % 0.63 % 35.59 %
Seq. Operating Income Change (Q4 MRQ) 0 % 14.27 % 39.78 % 8.27 %
Y / Y Operating Income Growth (Q4 TTM) - -13.23 % 7.71 % 29.22 %
Seq. Operating Income Growth (Q4 TTM) -46.42 % -5.46 % -1.46 % 24.17 %
Operating Income 5 Year Avg. Change - 14.94 % -0.82 % 13.21 %

Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) -45.9 % -15.45 % -1.56 % 27.81 %
Seq. Income from Cont. Ops. Change (Q4 MRQ) 0 % 26.44 % 124.99 % 23.47 %
Y / Y Income from Cont. Ops. Change (Q4 TTM) - -20.5 % -10.7 % 10.16 %
Seq. Income from Cont. Ops. Change (Q4 TTM) -45.9 % -7.03 % -4.19 % 6.8 %
Income from Cont. Ops. 5 Year Avg. Change - 12.87 % 1.33 % 15.47 %

CASI Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) -45.9 % -15.55 % -2.1 % 22.56 %
Q / Q Net Income Growth (Q4 MRQ) 0 % 25 % 104.57 % 18.63 %
Y / Y Net Income Change (Q4 TTM) - -20.56 % -7.69 % 10.87 %
Seq. Net Income Change (Q4 TTM) -45.9 % -7.02 % -4.6 % 5.85 %
Net Income 5 Year Avg. Growth - 24.55 % 4.55 % 15.45 %

CASI's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) -11.06 % -90.38 % -1.56 % 27.81 %
Seq. EPS from Cont. Ops. Change (Q4 MRQ) 0 % -81.37 % 124.99 % 23.47 %
Y / Y EPS from Cont. Ops. Change (Q4 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q4 TTM) -11.04 % - - 9.11 %
EPS from Cont. Ops. 5 Year Avg. Growth - NAN % 1.33 % 15.47 %

You need to upgrade your Flash Player

CASI EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) -11.06 % -90.39 % -2.1 % 15.47 %
Q / Q EPS Net Growth (Q4 MRQ) 0 % -81.58 % 104.57 % 18.63 %
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - - - 23.63 %
Seq. EPS Net Change (for 12 months ending Q4 TTM) -11.04 % - - 9.43 %
EPS Net 5 Year Avg. Change - 24.55 % 4.55 % 15.45 %
Expected EPS Growth (Y/Y) - - 123.59 % 27.58 %



Casi Pharmaceuticals saw it's income per share fall by -11.06% from the same quarter a year ago, in the forth quarter, Casi Pharmaceuticals was still better off than the Biotechnology & Drugs industry reporting -90.39% but underperformed the -2.1% EPS decrease in the Healthcare sector. Slow forth quarter 2016 income per share, in Biotechnology & Drugs industry and within the Healthcare sector, were portrayed in Casi Pharmaceuticals, Inc. results which underperformed overall market.

Sequentially company's EPS were unchanged from the forth quarter results. . Looking into annual growth, income per share grew by % on average in last five years, while S & P 500's including only Businesses with the forth quarter 2016 financial results, average yearly income per share growth is 15.45%.

CASI Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) - -18.3 % 14.28 % 3.3 %
Seq. Free Cash Flow Change (Q4 MRQ) - -36.48 % -38.59 % -49.64 %
Y / Y Free Cash Flow Change (Q4 TTM) - -0.47 % 8.32 % -1.12 %
Seq. Free Cash Flow Change (Q4 TTM) - -5.4 % -1.36 % -0.88 %
Free Cash Flow 5 Year Avg. Change - 11.55 % 5.21 % 15.98 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) - - - -15.69 %
Seq. Net Cash Flow Change (Q4 MRQ) - 169.85 % - -
Y / Y Net Cash Flow Change (Q4 TTM) 158.27 % - 37.16 % -65.86 %
Seq. Net Cash Flow Change (Q4 TTM) - - 18.48 % -41.68 %
Net Cash Flow 5 Year Avg. Change - - -17.35 % 25.64 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) -47.37 % 237.44 % 16.95 % 1.13 %
Seq. Capital Expenditures Change (Q4 MRQ) -47.63 % -60.24 % -36.99 % -37.34 %
Y / Y Capital Expenditures Change (Q4 TTM) 119.38 % 61.39 % 11.29 % -1.27 %
Seq. Capital Expenditures Change (Q4 TTM) -13.51 % 20.12 % 2.57 % -0.76 %
Capital Expenditures 5 Year Avg. Change - - - -

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com